CoChat
Sign Up
Cited by 1,207COVID-19 Impact on ReproductionCOVID-19 Clinical Research StudiesSARS-CoV-2 and COVID-19 Research

The DOI matches its Crossref record; 8 of the 8 references it cites were found in a registry or an index.

Update: characteristics of symptomatic women of reproductive age with laboratory-confirmed SARS-CoV-2 infection by pregnancy status - United States, January 22-October 3, 2020

Open access
Zambrano, Laura D., Ellington, Sascha, Strid, Penelope, Galang, Romeo R., Oduyebo, Titilope, Tong, Van T., Woodworth, Kate R., Nahabedian, John F., Azziz-Baumgartner, Eduardo, Gilboa, Suzanne M., Meaney-Delman, Dana, CDC COVID-19 Response Pregnancy and Infant Linked Outcomes Team, CDC COVID-19 Response Pregnancy and Infant Linked Outcomes Team, Akosa, Amanda, Bennett, Carolyne, Burkel, Veronica, Chang, Daniel, Delaney, Augustina, Fox, Charise, Griffin, Isabel, Hsia, Jason, Krause, Katie, Lewis, Elizabeth, Manning, Susan, Mohamoud, Yousra, Newton, Suzanne, Neelam, Varsha, Olsen, Emily O’Malley, Perez, Mirna, Reynolds, Megan, Riser, Aspen, Rivera, Maria, Roth, Nicole M., Sancken, Christina, Shinde, Neha, Smoots, Ashley, Snead, Margaret, Wallace, Bailey, Whitehill, Florence, Whitehouse, Erin, Zapata, Lauren·2020·MMWR Morbidity and Mortality Weekly Report
DOI 10.15585/mmwr.mm6944e3PMC PMC7643892
Open this paper in CoChat — free accountOpen PDF

Abstract

Studies suggest that pregnant women might be at increased risk for severe illness associated with coronavirus disease 2019 (COVID-19) (1,2). This report provides updated information about symptomatic women of reproductive age (15-44 years) with laboratory-confirmed infection with SARS-CoV-2, the virus that causes COVID-19. During January 22-October 3, CDC received reports through national COVID-19 case surveillance or through the National Notifiable Diseases Surveillance System (NNDSS) of 1,300,938 women aged 15-44 years with laboratory results indicative of acute infection with SARS-CoV-2. Data on pregnancy status were available for 461,825 (35.5%) women with laboratory-confirmed infection, 409,462 (88.7%) of whom were symptomatic. Among symptomatic women, 23,434 (5.7%) were reported to be pregnant. After adjusting for age, race/ethnicity, and underlying medical conditions, pregnant women were significantly more likely than were nonpregnant women to be admitted to an intensive care unit (ICU) (10.5 versus 3.9 per 1,000 cases; adjusted risk ratio [aRR] = 3.0; 95% confidence interval [CI] = 2.6-3.4), receive invasive ventilation (2.9 versus 1.1 per 1,000 cases; aRR = 2.9; 95% CI = 2.2-3.8), receive extracorporeal membrane oxygenation (ECMO) (0.7 versus 0.3 per 1,000 cases; aRR = 2.4; 95% CI = 1.5-4.0), and die (1.5 versus 1.2 per 1,000 cases; aRR = 1.7; 95% CI = 1.2-2.4). Stratifying these analyses by age and race/ethnicity highlighted disparities in risk by subgroup. Although the absolute risks for severe outcomes for women were low, pregnant women were at increased risk for severe COVID-19-associated illness. To reduce the risk for severe illness and death from COVID-19, pregnant women should be counseled about the importance of seeking prompt medical care if they have symptoms and measures to prevent SARS-CoV-2 infection should be strongly emphasized for pregnant women and their families during all medical encounters, including prenatal care visits. Understanding COVID-19-associated risks among pregnant women is important for prevention counseling and clinical care and treatment.

Overview

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.15585/mmwr.mm6944e3

Cites

8 of 8 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 8 references

Cited by

Sorted by citations

Items 901–1,000 of 1,000

Related

See all

Metadata

Authors
Zambrano, L. D., Ellington, S., Strid, P., Galang, R. R., Oduyebo, T., Tong, V. T., Woodworth, K. R., Nahabedian, J. F., Azziz-Baumgartner, E., Gilboa, S. M., Meaney-Delman, D., CDC COVID-19 Response Pregnancy and Infant Linked Outcomes Team, CDC COVID-19 Response Pregnancy and Infant Linked Outcomes Team, Akosa, A., Bennett, C., Burkel, V., Chang, D., Delaney, A., Fox, C., Griffin, I., Hsia, J., Krause, K., Lewis, E., Manning, S., Mohamoud, Y., Newton, S., Neelam, V., Olsen, E. O., Perez, M., Reynolds, M., Riser, A., Rivera, M., Roth, N. M., Sancken, C., Shinde, N., Smoots, A., Snead, M., Wallace, B., Whitehill, F., Whitehouse, E., & Zapata, L.
Affiliations
  • CDC COVID-19 Response Team.
  • Oak Ridge Institute for Science and Education (US)
Corresponding author
Zambrano, Laura D.
ORCID
Venue
MMWR Morbidity and Mortality Weekly Report
Publisher
Centers for Disease Control MMWR Office
Published
2020-11-06
Volume
69
Issue
44
Pages
1641-1647
ISSN
  • 0149-2195 (ISSN-L)
  • 1545-861X
DOI
10.15585/mmwr.mm6944e3
PMC
PMC7643892
OpenAlex
W3095574656
Cited by
1,207
References
8
Citations by year
2026: 25 · 2025: 49 · 2024: 127 · 2023: 226 · 2022: 353 · 2021: 412 · 2020: 14
FWCI
154.02
Type
journal article
Language
en
Open access
Locations
  • MMWR Morbidity and Mortality Weekly Report (publishedVersion)
  • PubMed Central (publishedVersion, cc-by)
  • PubMed (publishedVersion)
Funders
Centers for Disease Control and Prevention
Topics
  • Health Sciences › Medicine › Obstetrics and Gynecology › COVID-19 Impact on Reproduction
  • Health Sciences › Medicine › Infectious Diseases › COVID-19 Clinical Research Studies
  • Health Sciences › Medicine › Infectious Diseases › SARS-CoV-2 and COVID-19 Research
Keywords
COVID-19 pandemic, SARS-CoV-2, pregnancy, pregnant women, women of reproductive age, severe illness, intensive care unit admission, invasive mechanical ventilation, extracorporeal membrane oxygenation, mortality, racial and ethnic disparities, age disparities, health disparities, risk factors, sex differences, maternal health, case surveillance, notifiable diseases
MeSH terms
Betacoronavirus, COVID-19, SARS-CoV-2, COVID-19 Testing, Adolescent, Adult, Female, Humans, Laboratories, Pneumonia, Viral, Pregnancy, Pregnancy Complications, Infectious, Severity of Illness Index, United States, Coronavirus Infections, Risk Assessment, Clinical Laboratory Techniques, Young Adult, Pandemics, Symptom Assessment

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review